ApprovalTrail

Ingredient

Tacrolimus

Products in Health Canada’s databases that list Tacrolimus as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.

Also listed as “Tacrolimus (Tacrolimus Monohydrate)” (7). How names are joined

Drug products
36
32 authorized now
Natural health products
0
0 active licences
Notices of Compliance
66
Products in all
36

Drug products

Authorized products first.

NameDINStatus
ACH-TACROLIMUS (0.5 MG)Accord Healthcare Inc · Status since Sep 202302454068Marketed
ACH-TACROLIMUS (1 MG)Accord Healthcare Inc · Status since Sep 202302456095Marketed
ACH-TACROLIMUS (5 MG)Accord Healthcare Inc · Status since Sep 202302456109Marketed
ADVAGRAF (0.5 MG)Astellas Pharma Canada Inc · Status since Apr 200802296462Marketed
ADVAGRAF (1 MG)Astellas Pharma Canada Inc · Status since Apr 200802296470Marketed
ADVAGRAF (5 MG)Astellas Pharma Canada Inc · Status since Apr 200802296489Marketed
ADVAGRAF (3 MG)Astellas Pharma Canada Inc · Status since Apr 201002331667Marketed
ENVARSUS PA (0.75 MG)Knight Therapeutics Inc. · Status since Mar 202602485877Marketed
ENVARSUS PA (1 MG)Knight Therapeutics Inc. · Status since Mar 202602485885Marketed
ENVARSUS PA (4 MG)Knight Therapeutics Inc. · Status since Mar 202602485893Marketed
PROGRAF (5 MG)Astellas Pharma Canada Inc · Status since Apr 200602175983Marketed
PROGRAF (1 MG)Astellas Pharma Canada Inc · Status since Apr 200602175991Marketed
PROGRAF (5 MG)Astellas Pharma Canada Inc · Status since Sep 200502176009Marketed
PROGRAF (0.5 MG)Astellas Pharma Canada Inc · Status since Nov 200502243144Marketed
PROTOPIC (0.1 %)Leo Pharma Inc · Status since May 201702244148Marketed
PROTOPIC (0.03 %)Leo Pharma Inc · Status since May 201702244149Marketed
SANDOZ TACROLIMUS (0.5 MG)Sandoz Canada Inc. · Status since Jun 201402416816Marketed
SANDOZ TACROLIMUS (1 MG)Sandoz Canada Inc. · Status since Nov 201302416824Marketed
SANDOZ TACROLIMUS (5 MG)Sandoz Canada Inc. · Status since Nov 201302416832Marketed
SANDOZ TACROLIMUS XR (0.5 MG)Sandoz Canada Inc. · Status since Apr 202602528592Marketed
SANDOZ TACROLIMUS XR (1 MG)Sandoz Canada Inc. · Status since Nov 202502528606Marketed
SANDOZ TACROLIMUS XR (3 MG)Sandoz Canada Inc. · Status since Nov 202502528622Marketed
SANDOZ TACROLIMUS XR (5 MG)Sandoz Canada Inc. · Status since Nov 202502528630Marketed
APO-TACROLIMUS (0.5 MG)Apotex Inc. · Status since Apr 201702459213Approved
APO-TACROLIMUS (1 MG)Apotex Inc. · Status since Apr 201702459477Approved
APO-TACROLIMUS (5 MG)Apotex Inc. · Status since Apr 201702459485Approved
APO-TACROLIMUS CAPSULES (1 MG)Apotex Inc. · Status since Dec 202302474506Approved
APO-TACROLIMUS CAPSULES (5 MG)Apotex Inc. · Status since Dec 202302474514Approved
JAMP TACROLIMUS OINTMENT (0.1 %)JAMP Pharma Corporation · Status since Jun 202602569264Approved
LEO PHARMA - TACROLIMUS (0.1 %)Leo Pharma Gen, A Division Of Leo Pharma Inc. · Status since Sep 202202531380Approved
LEO PHARMA - TACROLIMUS (0.03 %)Leo Pharma Gen, A Division Of Leo Pharma Inc. · Status since Sep 202202531399Approved
SANDOZ TACROLIMUS XR (2 MG)Sandoz Canada Inc. · Status since Jul 202202528614Approved
JAMP-TACROLIMUS (0.5 MG)JAMP Pharma Corporation · Status since Sep 202202460238Cancelled Pre Market
JAMP-TACROLIMUS (1 MG)JAMP Pharma Corporation · Status since Sep 202202460246Cancelled Pre Market
JAMP-TACROLIMUS (5 MG)JAMP Pharma Corporation · Status since Sep 202202460254Cancelled Pre Market
TARO-TACROLIMUS (5 MG)Sun Pharma Canada Inc. · Status since Feb 202302453428Cancelled Pre Market

Notices of Compliance

Approvals of drug submissions that list it, newest first.